Epha2+/− mice exhibited mild ACC up to 45 weeks of age and moderate ACC (grade >2) by 64 weeks of age compared to age-matched Epha2+/+ mice (P < 0.01; see Figs. 10A, 11, Supplementary Table S3). This evidence concerns the gene EPHA2 and adrenal cortex carcinoma.